Meridian™
Universe

PMCB · CIK 0001157075 · FY2025 live · 2025-04-30

PharmaCyte Biotech, Inc.

SafeSEC 10-KClassic ZHealthcare95th percentile in Healthcare · 736 names

View as

Model

Classic Z

FY2025

7.51

Zone

Safe

Prior

—

Market DD

—

1y PD

—

Meridian Rank

82.91

0–100 · Classic Z tape · not a PD

  • Book standing

    96

  • Year change

    —

  • Market PD

    —

  • O-score

    48

Events on this name

Same published rows as Today. Not a live recompute.

  • Approaching grey

    watch · 41

    • Live Z: — → 7.51
    • Cut: — → 1.80

7.51

Z″ 13.39

−21.83.08+

Score 7.51 · distress below 1.80, grey to 2.99, safe at 3.00 and above.

Classic Z factor contributions

  • X1 Working capital / assets

    Short-term liquidity versus the size of the balance sheet.

    0.35
    1.2 × = 0.42

  • X2 Retained earnings / assets

    Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.

    −1.54
    1.4 × = −2.16

  • X3 EBIT / assets

    Operating return on assets. Highest weight in the original model.

    −0.08
    3.3 × = −0.26

  • X4 Book equity / liabilities

    Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.

    15.83
    0.6 × = 9.50

  • X5 Sales / assets

    Asset turnover — how much revenue the asset base supports.

    0.00
    1 × = 0.00

Five-year path

Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.

Overview

rule-v1

PharmaCyte Biotech, Inc. is on classic Z at 7.51 (safe) for FY2025, from an SEC 10-K. Book equity / liabilities is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.

Book screen Safe; market PD —. Tape not priced — not a single default call.

Market DD · naive Merton

No market tape yet.

Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.

Sector peers

Closest Classic Z scores · 95th percentile in Healthcare.

KPI widgets

Current assets

$22M

Total assets

$55M

Current liabilities

$3M

Total liabilities

$3M

Working capital

$19M

Retained earnings

−$85M

EBIT

−$4M

Total sales

$0

Book equity

$52M

Accession 0001683168-25-005821. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-04-30). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.